// App-Quantinova.ai

e16526 : Androgen deprivation therapy alone or with docetaxel in hormone naive metastatic prostate cancer: Meta-analysis of randomized phase III trials.

Researchers

Presenter

  • Jamal Zekri

Principal Investigators

  • Imran Ahmad

  • Saba Imtiaz

  • Rawan Al-Saadi

Medical Centers

  • King Faisal Specialist Hospital and Research Center, Al-Faisal University, Jeddah, Saudi Arabia

  • King Faisal Specialist Hospital and Research Center, Al-Faisal University, Jeddah, Saudi Arabia

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

Locations

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Androgen Tear

Outcome

  • Positive


Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final